BRAMBILLA, GIANMARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.400
AS - Asia 2.140
EU - Europa 1.771
SA - Sud America 322
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 8.703
Nazione #
US - Stati Uniti d'America 4.102
SG - Singapore 827
CN - Cina 439
DE - Germania 341
VN - Vietnam 283
RU - Federazione Russa 271
CA - Canada 270
HK - Hong Kong 262
SE - Svezia 260
BR - Brasile 232
IE - Irlanda 205
IT - Italia 181
UA - Ucraina 163
FR - Francia 108
GB - Regno Unito 98
IN - India 78
BD - Bangladesh 54
FI - Finlandia 53
AR - Argentina 32
KR - Corea 26
TR - Turchia 26
IQ - Iraq 24
BE - Belgio 19
JP - Giappone 17
PL - Polonia 16
NL - Olanda 15
ZA - Sudafrica 15
MX - Messico 13
PK - Pakistan 13
CO - Colombia 12
ES - Italia 12
CL - Cile 11
EC - Ecuador 11
ID - Indonesia 10
VE - Venezuela 10
PH - Filippine 9
SA - Arabia Saudita 9
EG - Egitto 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
MA - Marocco 7
UZ - Uzbekistan 7
ET - Etiopia 6
EU - Europa 6
LB - Libano 6
KE - Kenya 5
KZ - Kazakistan 5
TH - Thailandia 5
AT - Austria 4
AZ - Azerbaigian 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
AU - Australia 3
BG - Bulgaria 3
BJ - Benin 3
CH - Svizzera 3
DZ - Algeria 3
OM - Oman 3
PE - Perù 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
HN - Honduras 2
KH - Cambogia 2
LT - Lituania 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.703
Città #
Singapore 468
Ashburn 395
Woodbridge 365
Ann Arbor 351
Fairfield 273
Chandler 255
Hong Kong 255
Houston 254
San Jose 243
Frankfurt am Main 217
Toronto 206
Dublin 196
Jacksonville 175
Seattle 129
New York 118
Dearborn 116
Cambridge 112
Wilmington 108
Hanoi 79
Ho Chi Minh City 78
Princeton 74
Beijing 72
Los Angeles 71
Santa Clara 67
Chicago 64
Nanjing 50
The Dalles 42
Lauterbourg 37
Milan 35
Dallas 34
Lachine 33
Lawrence 32
Altamura 30
Boardman 29
Seoul 25
Shanghai 25
Buffalo 24
Moscow 24
São Paulo 24
Council Bluffs 22
Hefei 22
Munich 20
Brussels 17
Nanchang 17
Orem 17
Shenyang 16
Tianjin 16
Hebei 15
Ottawa 14
San Diego 14
Belo Horizonte 13
Helsinki 13
Tokyo 12
Baghdad 11
Chennai 11
Warsaw 11
Andover 10
Düsseldorf 10
Fremont 10
Guangzhou 10
Haiphong 10
Changsha 9
Da Nang 9
Hangzhou 9
London 9
Lissone 8
Montreal 8
Zhengzhou 8
Ningbo 7
Rio de Janeiro 7
Rome 7
Turku 7
Addis Ababa 6
Boston 6
Caracas 6
Columbus 6
Denver 6
Dhaka 6
Guayaquil 6
Jinan 6
Medellín 6
Miami 6
Norwalk 6
Porto Alegre 6
Salt Lake City 6
Santiago 6
Stockholm 6
Tampa 6
Atlanta 5
Cairo 5
Jiaxing 5
Johannesburg 5
Phoenix 5
Pune 5
Amsterdam 4
Bexley 4
Brno 4
Brooklyn 4
Chandigarh 4
Detroit 4
Totale 5.734
Nome #
The Pamela study: main findings and perspectives 309
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 303
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 303
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 292
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 291
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 284
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 284
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 276
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 270
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 269
New-onset left atrial enlargement in a general population 269
Role of ambulatory blood pressure monitoring in resistant hypertension 268
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study 263
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 248
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 246
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 241
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease 234
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 233
Targets for body fat, blood pressure, lipids, and glucose-lowering interventions in healthy older people 232
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 230
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 229
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 229
Failure of monolateral renal nerve ablation to exert sympathoinhibitory and blood pressure lowering effects in a patient with resistant hypertension: a case report 228
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 221
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 220
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 216
Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension 205
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 203
Effects of Renal Denervation on Sympathetic Nervous System Activity 198
The role of carotid baroreceptor stimulation 197
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 196
The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation 193
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 193
Dissociation between the behaviour of arterial stiffness and muscel sympathetic nerve traffic in patients with htart failure treated with chronic baroreflex activation 163
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study 157
CPAP in acute pulmonary edema. Our experience of the nurse role in the out of hospital life support 145
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study 141
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 136
Totale 8.815
Categoria #
all - tutte 29.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022396 9 36 39 39 35 27 12 25 20 39 38 77
2022/2023882 92 327 70 82 33 144 3 62 54 3 9 3
2023/2024576 12 20 25 46 73 149 130 24 37 4 3 53
2024/20251.235 66 165 59 50 117 18 40 64 171 190 108 187
2025/20262.999 330 126 223 293 403 140 415 124 265 336 275 69
Totale 8.815